Sutekast (Sunitinib) 50 mg Capsules (28 Count)

Indicated for the treatment of:

• Advanced Renal Cell Carcinoma (RCC): Kidney cancer.
• Gastrointestinal Stromal Tumors (GIST): After disease progression on or intolerance to Imatinib.
• Pancreatic Neuroendocrine Tumors (pNET).

Strength: 50 mg capsule.

Standard Schedule "4/2" (for RCC & GIST):

• 📅 4 Weeks ON: Take one 50 mg capsule daily.
• 📅 2 Weeks OFF: No medication (rest period).

Repeat this 6-week cycle.

⚠️ Instructions:

• Can be taken with or without food.
• Do not crush or open the capsule (contents are yellow and staining).
• Avoid Grapefruit and St. John's Wort.

• Pregnancy and breastfeeding (Category D).
• Severe bleeding disorders.
• Severe cardiac arrhythmias (QT prolongation).
• Uncontrolled hypertension.

Patients should be aware of unique side effects:

• 🟡 Yellow Discoloration: Skin and possibly hair may turn yellowish due to the active ingredient's color. This is reversible.
• Hand-Foot Syndrome: Pain, swelling, and blisters on palms and soles.
• Stomatitis: Mouth sores or altered taste.
• Hypertension and Fatigue.